Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Phase of Trial: Phase III
Latest Information Update: 17 Mar 2016
At a glance
- Drugs Mirtazapine (Primary)
- Indications Anxiety
- Focus Therapeutic Use
- 14 Mar 2016 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018 as per ClinicalTrials.gov record.
- 14 Mar 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018 as per ClinicalTrials.gov record.
- 23 Oct 2012 Lead trial centre amended as reported by ClinicalTrials.gov.